Duzono P 30mg/75mg Tablet
Prescription Required
Introduction of Duzono P Tablet
Duzono P 30mg/75mg Tablet is used for the treatment of neuropathic pain. It decreases pain by controlling calcium channel activity of the nerve cells. It also increases the level of chemical messengers in the brain that helps maintain mental balance and stop the movement of pain signals in the brain.
Duzono P 30mg/75mg Tablet is a combination of alpha 2 delta ligands (AEDs) and serotonin-norepinephrine reuptake inhibitors (SNRIs).
Duzono P 30mg/75mg Tablet is a combination of alpha 2 delta ligands (AEDs) and serotonin-norepinephrine reuptake inhibitors (SNRIs).
Uses of Duzono P Tablet
Benefits of Duzono P Tablet
In Neuropathic pain
Duzono P 30mg/75mg Tablet is a combination of medicines used to treat long-lasting (chronic) pain caused by nerve damage due to diabetes, shingles or spinal cord injury. It reduces pain and its associated symptoms such as mood changes, sleep problems, and tiredness. Pregabalin, an active ingredient of this medicine, is thought to work by interfering with pain signals that travel through the damaged nerves and the brain. It also improves nerve conduction and enhances the quality of life.
Side effects of Duzono P Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Duzono P
- Nausea
- Constipation
- Insomnia (difficulty in sleeping)
- Sleepiness
- Headache
- Dizziness
- Tiredness
- Ejaculation disorder
- Erectile dysfunction
- Uncoordinated body movements
How to use Duzono P Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Duzono P 30mg/75mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Safety advice
Alcohol
UNSAFE
It is unsafe to consume alcohol with Duzono P 30mg/75mg Tablet.
Pregnancy
CONSULT YOUR DOCTOR
Duzono P 30mg/75mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Duzono P 30mg/75mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
UNSAFE
Duzono P 30mg/75mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney
CAUTION
Duzono P 30mg/75mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Duzono P 30mg/75mg Tablet may be needed. Please consult your doctor.
Liver
UNSAFE
Duzono P 30mg/75mg Tablet is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
Duzono P Tablet
- Duzono P 30mg/75mg Tablet is used for treating nerve pain caused by diabetes, shingles, fibromyalgia, and spinal cord injuries.
- You may have to wait for 2 to 4 weeks before it starts working.
- It may cause dizziness during the first few weeks. Don't drive or do anything requiring concentration until you know how Duzono P 30mg/75mg Tablet affects you.
- Avoid consuming alcohol when taking this medicine as it may cause excessive drowsiness and increase the risk of liver damage.
- Monitor your blood pressure regularly, especially during the first month of treatment.
- It may cause a sensation of restlessness or an inability to sit or stand still, especially when you first start taking it. Inform your doctor if this happens to you.
- Inform your doctor if you develop any unusual changes in mood or behavior, new or worsening depression, or suicidal thoughts or behavior.
- Do not stop taking the medication suddenly without talking to your doctor.
Fact Box
Habit Forming
No
Therapeutic Class
NEURO CNS
Patient concerns
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Tesfaye S, Wilhelm S, Lledo A, et al. Duloxetine and pregabalin: High-dose monotherapy or their combination? The “COMBO-DN study” – a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain. Pain. 2013;154(12):2616-25. [Accessed 29 Apr. 2019] (online) Available from:
- Pregabalin. Vega Baja, Puerto Rico: Pfizer Pharmaceuticals LLC; 2009. [Accessed 23 Jan. 2019] (online) Available from:
- Duloxetine hydrochloride. Basingstoke, Hampshire: Eli Lilly and Company Limited; 2004 [revised 09 Nov. 2018]. [Accessed 23 Jan. 2019] (online) Available from:
- Pregablin. New York, New York: Pfizer; 2004 [revised Jun 2011]. [Accessed 22 Mar. 2019] (online) Available from:
- Medscape. Duloxetine. [Accessed 24 Apr. 2019] (online) Available from:
Marketer details
Name: Arinna Lifescience Pvt Ltd
Address: A – 504, Shapath-4, B/S Hotel Crowne Plaza, Opp. Karnavati Club, S. G. Highway ,Ahmedabad 380 051 Gujarat
Country of origin: India
Lab tests offered by us
Related/Popular tests
MRP
₹239
Inclusive of all taxes
10.0 tablets in 1 strip
SOLD OUT
Notify me